Oct 30, 2020
This week: The study that identified factors associated with strong antibody responses to COVID; How convalescent plasmas benefits may be limited; A nasal spray to treat diabetic gastroparesis; Recommendations for colorectal cancer screening; And a new treatment approved for dry eye disease.
Oct 23, 2020
This week on the pod: Results from the survey assessing willingness to receive a COVID vaccine; Dr. Fauci shares that he is 'cautiously optimistic' a vaccine could arrive before year’s end; A short course of treatment for tuberculosis shows promise; Phase 3 results for a novel pneumococcal vaccine; The FDA rejects a...
Oct 16, 2020
This week: News of another vaccine trial being put on hold; A trial assessing hyperimmue globulin beings; An NDA for IV tramadol is rejected; FDA Committees vote on novel schizophrenia and bipolar I disorder therapy; And a first approval for Ebola.
Oct 9, 2020
This week on the pod; the latest COVID news, including encouraging news on antibody therapies; Updated on Emergency Use Authorization guidelines for vaccines; Remdesivir distribution; A HIV drug fails to have an impact; And why the FDA want a preterm birth treatment withdrawn from the market.
Oct 2, 2020
New Moderna vaccine results; Boxed Warning for benzodiazepines; Point-of-care COVID-19 antibody test; Diphenhydramine overdoses linked to TikTok ‘Challenge’; And FDA grants Nucala new approval. Also we look at this week's developments in drugs in the pipeline.